首页 > 市场调查报告书 > 製药

处方药循环系统

市场调查报告书

商品编码

1789532

Manjaro 市场：依强度、剂型、通路和地区划分

Mounjaro Market, By Strength, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2025年07月04日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年 Manjaro 市场规模将达到 167.8 亿美元，到 2032 年将达到 554.8 亿美元，2025 年至 2032 年的复合年增长率为 18.6%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	167.8亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	18.60%	2032年价值预测	554.8亿美元

全球 Munjaro 市场是製药业的一个革命性领域，以礼来公司开发的突破性葡萄糖依赖性胰岛素促泌多肽(GIP) 和Glucagon-Like Peptide-1(GLP-1) 受体双重促效剂tirzepatide 为中心。 Munjaro 已成为一种突破性的治疗药物，主要用于治疗第 2 型糖尿病，在血糖控制和显着减肥方面表现出色。这种创新药物利用独特的双激素方法同时靶向 GIP 和 GLP-1 受体，增强胰岛素分泌，抑制升糖素分泌，减缓排放，从而实现比传统单一疗法更好的血糖控制。正在进行的临床试验正在探索其在肥胖治疗和降低心血管风险方面的潜在应用，将 Munjaro 定位为多用途治疗药物。製药业对联合治疗和个人化医疗的日益关注进一步激发了人们对 Munjaro 双重作用机制的兴趣。 Manjaro 是不断发展的糖尿病照护生态系统中的基石产品，它确立了其作为具有巨大增长潜力的优质治疗选择的市场地位。

市场动态

全球 Manjaro 市场受到多个强劲驱动因素的支撑，突显了其强劲的成长轨迹和市场渗透潜力。首要驱动因素是全球 2 型糖尿病盛行率的上升，国际糖尿病联盟预测，到 2045 年，全球糖尿病患者将超过 7 亿，这将对 Manjaro 等创新治疗方案产生前所未有的需求。该药物卓越的临床疗效，在 III 期临床试验中得到证实，可使体重减轻高达 15%，并显着改善糖化血红蛋白 (HbA1c)，使其成为寻求全面糖尿病管理的医疗保健提供者和患者的首选。此外，人们对糖尿病相关併发症的认识不断提高以及人们转向预防性医疗保健，正在推动市场采用该药物，而新兴市场优惠的报销政策和扩大的保险覆盖范围也进一步加速了市场采用。然而，市场也面临许多製约因素。例如，Manjaro 的高定价可能会限制其在价格敏感型市场和新兴经济体的供应，从而限制其全球应用。供应链挑战以及对製造扩充性的担忧（尤其是在需求高峰期），构成了营运限制，可能会影响市场成长。此外，不同地理区域的监管复杂性以及新适应症的冗长核准流程，也为快速扩张市场带来了更多障碍。儘管面临这些挑战，Manjaro 不断扩展的治疗用途，尤其是在肥胖管理领域，也蕴藏着巨大的商机。临床试验已显示出良好的结果，并有望开闢新的收益来源和细分市场。远端医疗，为加强患者监测和依从性计划提供了机会，而与医疗保健系统和连锁药店建立战略合作伙伴关係，则可以改善市场进入和分销效率，最终促进全球糖尿病治疗市场的长期可持续增长。

本次调查的主要特点

本报告对全球 Manjaro 市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
它根据公司亮点、产品系列、关键亮点、业绩和策略等参数，概述了全球 Manjaro 市场的主要企业。
本研究涉及的主要企业包括礼来公司。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴车型、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球 Manjaro 市场的各种策略矩阵，相关人员可以更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 16.78 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	18.60%	2032 Value Projection:	USD 55.48 Bn

The global Mounjaro market represents a revolutionary segment within the pharmaceutical landscape, centered around tirzepatide, a groundbreaking dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly and Company. Mounjaro has emerged as a transformative therapeutic solution primarily indicated for the treatment of type 2 diabetes mellitus, demonstrating exceptional efficacy in glycemic control and significant weight reduction benefits. This innovative medication operates through a unique dual-hormone approach, simultaneously targeting both GIP and GLP-1 receptors to enhance insulin secretion, suppress glucagon release, and slow gastric emptying, thereby providing superior glucose management compared to traditional monotherapy approaches. The market's significance extends beyond diabetes management, as ongoing clinical trials explore Mounjaro's potential applications in obesity treatment and cardiovascular risk reduction, positioning it as a versatile therapeutic asset. The pharmaceutical industry's increasing focus on combination therapies and personalized medicine has further amplified interest in Mounjaro's dual-action mechanism, making it a cornerstone product in the evolving diabetes care ecosystem and establishing its market presence as a premium therapeutic option with substantial growth potential.

Market Dynamics

The global Mounjaro market is propelled by several compelling drivers that underscore its robust growth trajectory and market penetration potential. The primary driver stems from the escalating global prevalence of type 2 diabetes, with the International Diabetes Federation projecting over 700 million diabetes cases worldwide by 2045, creating an unprecedented demand for innovative therapeutic solutions like Mounjaro. The drug's superior clinical efficacy, demonstrated through Phase III trials showing up to 15% weight reduction and significant HbA1c improvements, positions it as a preferred choice among healthcare providers and patients seeking comprehensive diabetes management. Additionally, the growing awareness about diabetes-related complications and the shift toward preventive healthcare approaches drive market adoption, while favorable reimbursement policies and insurance coverage expansions in developed markets further accelerate uptake. However, the market faces notable restraints, including Mounjaro's premium pricing structure that limits accessibility in price-sensitive markets and developing economies, potentially restricting its global penetration. Supply chain challenges and manufacturing scalability concerns, particularly during peak demand periods, pose operational constraints that could impact market growth. Regulatory complexities across different geographical regions and the lengthy approval processes for new indications create additional barriers to rapid market expansion. Despite these challenges, significant opportunities emerge from Mounjaro's expanding therapeutic applications, particularly in obesity management where clinical trials demonstrate promising results, potentially opening new revenue streams and market segments. The increasing adoption of telemedicine and digital health platforms presents opportunities for enhanced patient monitoring and adherence programs, while strategic partnerships with healthcare systems and pharmacy chains could improve market access and distribution efficiency, ultimately driving sustainable long-term growth in the global diabetes therapeutics landscape.

Key Features of the Study

This report provides in-depth analysis of the global Mounjaro market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Mounjaro market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key company covered as a part of this study includes Eli Lilly and Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Mounjaro market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Mounjaro market.

Market Segmentation

Strength Insights (Revenue, USD Bn, 2022 - 2032)
- 15 mg
- 10 mg
- 5 mg
- 5 mg
- 5 mg
- 5 mg
Dosage Form Insights (Revenue, USD Bn, 2022 - 2032)
- Single-dose Pen
- Single-dose Vial
Distribution Channel Insights (Revenue, USD Bn, 2022 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2022 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Eli Lilly and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Mounjaro Market, By Strength
- Global Mounjaro Market, By Dosage Form
- Global Mounjaro Market, By Distribution Channel
- Global Mounjaro Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
Patent Landscape
Country Approval Matrix

4. Global Mounjaro Market, By Strength, 2022-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2023 - 2032
- Segment Trends
15 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
10 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
12.5 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
7.5 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
5 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
2.5 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)

5. Global Mounjaro Market, By Dosage Form, 2022-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2023 - 2032
- Segment Trends
Single-dose Pen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
Single-dose Vial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)

6. Global Mounjaro Market, By Distribution Channel, 2022-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2023 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2022 - 2032, (USD Bn)

7. Global Mounjaro Market, By Region, 2023 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2023 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Strength, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Strength, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Strength, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Strength, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Strength, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2022 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Strength, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2022 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2022 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

9. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

10. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

Manjaro 市场：依强度、剂型、通路和地区划分

Mounjaro Market, By Strength, By Dosage Form, By Distribution Channel, By Geography

市场动态

目录

第一章：调查目标和先决条件

第二章市场展望

第三章：市场动态、法规与趋势分析

4. 2022 年至 2032 年全球 Manjaro 市场（按强度）

5. 全球 Manjaro 市场（依剂型划分），2022 年至 2032 年

6. 全球 Manjaro 市场（依分销管道划分），2022-2032 年

7. 全球 Manjaro 市场（按地区），2023-2032

第八章竞争态势

第九章分析师建议

第十章参考文献与调查方法